| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/15/2005 | EP1066059B1 Formulations for protection of peg-interferon alpha conjugates |
| 06/15/2005 | EP1066050B1 Application of hsp70 proteins |
| 06/15/2005 | EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 06/15/2005 | EP1061923B1 Metal chelators for use in the treatment of alzheimer's disease |
| 06/15/2005 | EP1007068B1 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 06/15/2005 | EP1005359B1 FRACTURE HEALING USING PTHrP ANALOGS |
| 06/15/2005 | EP1001979B1 Cyclic azapeptides with angiogenic effect |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | EP0977564B1 Forskolin for promoting lean body mass |
| 06/15/2005 | EP0975608B1 Halo-alkoxycarbonyl prodrugs |
| 06/15/2005 | EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 06/15/2005 | EP0906108B1 Endothelin antagonists for treating heart failure |
| 06/15/2005 | CN1628128A Mammal prolactin variants |
| 06/15/2005 | CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 06/15/2005 | CN1628115A 哌啶衍生物 Piperidine derivatives |
| 06/15/2005 | CN1628113A Substituted indoles as alpha-1 agonists |
| 06/15/2005 | CN1628112A Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-dollar G (A), dollar G (A)-dimethyl-benzeneacetic |
| 06/15/2005 | CN1628111A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |
| 06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1628106A Salts of valsartan |
| 06/15/2005 | CN1628102A Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B) |
| 06/15/2005 | CN1628100A Gamma secretase inhibitors |
| 06/15/2005 | CN1627970A Safety shield system for prefilled syringe |
| 06/15/2005 | CN1627961A Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues |
| 06/15/2005 | CN1627957A Hair growth stimulants, percutaneous preparations and method of stimulating hair growth |
| 06/15/2005 | CN1627955A Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytoch rome P-45O |
| 06/15/2005 | CN1627954A Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 06/15/2005 | CN1627946A Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers |
| 06/15/2005 | CN1627945A Quinoline derivatives as NPY antagonists |
| 06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 06/15/2005 | CN1626679A Methods for assessing and treating cancer |
| 06/15/2005 | CN1626652A Method for accelerating quick growth of animals and method for improving quality of meat |
| 06/15/2005 | CN1626533A Process for preparation of sulfonamide derivs. and crystals thereof |
| 06/15/2005 | CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones |
| 06/15/2005 | CN1626240A Antigen-specific lgE antibody production inhibitors |
| 06/15/2005 | CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 06/15/2005 | CN1626191A Preparation of Chinese traditional medicine for enhancing and consolidating memory |
| 06/15/2005 | CN1626173A Sugarless type oral liquid of rehmannia root including six elements |
| 06/15/2005 | CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 06/15/2005 | CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/15/2005 | CN1206363C Process for obtaining of HMG-CO a reductase inhibitors of high purify |
| 06/15/2005 | CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206224C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/15/2005 | CN1205999C Liposone composition and method for administration of a radiosensitizer |
| 06/15/2005 | CN1205998C Antigen-specific IgE antibody production inhibitors |
| 06/15/2005 | CN1205995C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/15/2005 | CN1205984C Medicine composition with synergrstic action and preparation process and use thereof |
| 06/15/2005 | CN1205955C Composition with intelligence-development, immunological regulation and fatigue resistance |
| 06/15/2005 | CN1205935C Highly selective norepinephrine reuptake inhibitors and methods of using same |
| 06/15/2005 | CN1205923C Liposome-entrapped topoisomerase inhibitors |
| 06/15/2005 | CN1205921C Long acting injectable formulations contg. hydrogenated castor oil |
| 06/14/2005 | US6906204 Processing method of lactionization in the preparation of statins |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906196 Antiinflammatory agents, rheumatic disorders |
| 06/14/2005 | US6906193 N-type calcium channel antagonists for the treatment of pain |
| 06/14/2005 | US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. |
| 06/14/2005 | US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 06/14/2005 | US6906104 Aminediols for the treatment of Alzheimer's disease |
| 06/14/2005 | US6906103 Compounds possessing antibacterial, antifungal or antitumor activity |
| 06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/14/2005 | US6906087 Antidepressant; storage stability |
| 06/14/2005 | US6906086 Methods for inhibiting bone loss |
| 06/14/2005 | US6906085 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906083 Alzheimer's disease; brain disorders |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906081 For treatment of Alzheimer's disease, learning disabilities |
| 06/14/2005 | US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism |
| 06/14/2005 | US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH |
| 06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906063 For therapy and prophylaxis of thrombosis in a mammal |
| 06/14/2005 | US6906058 Prevent bile acid transportation; anticholesterol agents |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6906049 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
| 06/14/2005 | US6906044 Regeneration of articular cartilage damaged by grade I and II osteoarthritis by means of the intraarticular application of a mixture of sodium hyaluronate and chondroitin sulfate in a gel vehicle |
| 06/14/2005 | US6906040 Method for reducing toxicity of combined chemotherapies |
| 06/14/2005 | US6905856 Soluble GlcNAc phosphotransferase |
| 06/14/2005 | US6905844 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/14/2005 | US6905832 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP) |
| 06/14/2005 | US6905704 Animal extracts; hypotensive agent; storage stability |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | CA2420576C Immunoregulatory compounds, derivatives thereof and their use |
| 06/14/2005 | CA2339782C Polyamine treatment of neurological disorders |
| 06/14/2005 | CA2333703C Isothiazole derivatives useful as anticancer agents |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/14/2005 | CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 06/14/2005 | CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 06/14/2005 | CA2136008C Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation |
| 06/14/2005 | CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity |
| 06/09/2005 | WO2005051993A1 Novel muscle growth regulator |
| 06/09/2005 | WO2005051955A1 Novel compound and medicinal composition |
| 06/09/2005 | WO2005051949A1 Novel condensed imidazole derivative |
| 06/09/2005 | WO2005051912A1 Piperidine compound and method for producing same |